Mirati Therapeutics Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones.

Biotechnology

Mirati Therapeutics

Charles M. Baum

Jennifer Colon

Alexas Williamson

Jing He

Bifeng D.

Kelly Pearson

Charlie Jones

Mehrdad Kheiripour

Vanessa Tassell

Shilpen Patel

Mason Israel

Bill Paxton M.D. Fcap

Debbie Ryan

Mario Guzman

Katie McGinn

Jim Halsey

Jim Shanley

Alex Pennock

Lauren Schroeder

Jennifer Moller

Cory Bartlett

Enkhe Badamgarav M.D.

Dan Thompson

Maggie Ryan Laughlin

Corey Pecoraro

Romel Montellano

Maika Adair

Barry Lennon

Paul Stephensen

Mike Dwyer

Susan Welsh

Peter Lee

Betsy Gelfand

John Moriarty

Jessica Corson

Ryan Asay

James Christensen

The executive team at Mirati Therapeutics has a long history of experience in the pharmaceutical industry. They have worked at various companies, including Pfizer, Pharmacia Corporation, and SUGEN. They have also consulted for a number of biotech companies. In addition, they have a strong educational background, with degrees in chemical engineering from Rensselaer Polytechnic Institute and Louisiana State University.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Mirati Therapeutics

Leadership Team

Board of Directors